Novo CEO pressed by Senate to chop charges of weight problems, diabetes medication CEO Lars Fruergaard Jørgensen informed lawmakers the company would think about new talks with insurers with regard to the record costs of Wegovy and copyright if they pledge to keep the medicines on their own formularies. Before https://jeffreytkarh.blogunteer.com/29892864/the-ultimate-guide-to-healthcare-news